Stock LBIO LION BIOTECHNOLOGIES INC
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Insiders Lion Biotechnologies Inc OTC Bulletin Board

Equities

LBIO

US53619R1023

End-of-day quote OTC Bulletin Board
Other stock markets
- USD - Intraday chart for Lion Biotechnologies Inc
06-11 Iovance Biotherapeutics, Inc. Elects Frederick G. Vogt as Director CI
06-10 Transcript : Iovance Biotherapeutics, Inc. Presents at Goldman Sachs 45th Annual Global Healthcare Conference, Jun-10-2024 02:40 PM

Insiders

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Iovance Biotherapeutics, Inc. Elects Frederick G. Vogt as Director
CI
General (Ret.) Merrill A. McPeak, Member of the Board of Directors of Iovance Biotherapeutics, Inc. Retires and Not Stands for Re-Election
CI
Iovance Biotherapeutics Insider Bought Shares Worth $45,750,000, According to a Recent SEC Filing
MT
Iovance Biotherapeutics Insider Bought Shares Worth $292,800, According to a Recent SEC Filing
MT
Iovance Biotherapeutics Insider Bought Shares Worth $2,287,500, According to a Recent SEC Filing
MT
Iovance Biotherapeutics Insider Bought Shares Worth $26,500,000, According to a Recent SEC Filing
MT
Iovance Biotherapeutics, Inc. Announces Wendy Dixon, Member of Board of Directors, Will Not Stand for Re-Election
CI
Iovance Biotherapeutics, Inc. Appoints Wendy L. Yarno as Director and New Member of the Board
CI
TScan Therapeutics Names Debora Barton as Chief Medical Officer
MT
Iovance Biotherapeutics, Inc. Appoints Wendy L. Dixon to Board of Directors
CI
Iovance Biotherapeutics Announces Raj K. Puri as Executive Vice President, Regulatory Strategy and Translational Medicine
CI
Alpine Immune Sciences : Appoints Chief Medical Officer
MT
Iovance Biotherapeutics, Inc. Announces Management Changes
CI
Iovance Biotherapeutics, Inc. Appoints Igor Bilinsky as Chief Operating Officer
CI
Iovance Biotherapeutics, Inc. Announces Board Changes
CI
Iovance Biotherapeutics Appoints Jean-Marc Bellemin as Chief Financial Officer
CI
Iovance Biotherapeutics, Inc. Announces Executive Changes
CI
Iovance Biotherapeutics Appoints Friedrich Graf Finckenstein as Chief Medical Officer
CI
Iovance Biotherapeutics, Inc. Appoints Athena Countouriotis to its Board of Directors and Member of the Board’s Nominating and Corporate Governance Committee and the Compensation Committee
CI
Sanford J. Hillsberg Intends Not to Stand for Re-Election as Member of the Board of Directors of Iovance Biotherapeutics, Inc
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. IOVA Stock
  4. LBIO Stock
  5. News Lion Biotechnologies Inc
  6. Insiders